Simplex Trading, LLC Intra Cellular Therapies, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 3,220 shares of ITCI stock, worth $268,612. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,220
Previous 9,430 65.85%
Holding current value
$268,612
Previous $645,000 63.57%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$67.99 - $80.84 $422,217 - $502,016
-6,210 Reduced 65.85%
3,220 $235,000
Q2 2024

Jul 25, 2024
SELL
$64.76 - $79.84 $273,481 - $337,164
-4,223 Reduced 30.93%
9,430 $645,000
Q1 2024

Apr 25, 2024
BUY
$64.37 - $75.65 $164,658 - $193,512
2,558 Added 23.06%
13,653 $944,000
Q4 2023

Feb 02, 2024
BUY
$46.37 - $73.65 $514,475 - $817,146
11,095 New
11,095 $794,000
Q1 2023

Apr 27, 2023
BUY
$43.8 - $56.99 $1.58 Million - $2.06 Million
36,159 Added 584.25%
42,348 $2.29 Million
Q4 2022

Feb 02, 2023
SELL
$44.07 - $54.45 $231,014 - $285,426
-5,242 Reduced 45.86%
6,189 $327,000
Q3 2022

Nov 04, 2022
BUY
$42.7 - $59.99 $488,103 - $685,745
11,431 New
11,431 $531,000
Q2 2021

Aug 12, 2021
SELL
$29.3 - $44.5 $168,709 - $256,231
-5,758 Closed
0 $0
Q1 2021

Apr 26, 2021
SELL
$30.8 - $39.51 $649,294 - $832,910
-21,081 Reduced 78.55%
5,758 $195,000
Q4 2020

Feb 02, 2021
SELL
$23.34 - $32.22 $78,609 - $108,516
-3,368 Reduced 11.15%
26,839 $853,000
Q3 2020

Oct 14, 2020
SELL
$17.61 - $31.86 $324,499 - $587,084
-18,427 Reduced 37.89%
30,207 $775,000
Q2 2020

Jul 13, 2020
BUY
$14.35 - $26.64 $140,759 - $261,311
9,809 Added 25.26%
48,634 $1.25 Million
Q1 2020

Apr 29, 2020
BUY
$12.31 - $33.12 $15,609 - $41,996
1,268 Added 3.38%
38,825 $596,000
Q4 2019

Feb 05, 2020
SELL
$7.26 - $38.49 $164,468 - $871,952
-22,654 Reduced 37.62%
37,557 $1.29 Million
Q3 2019

Oct 15, 2019
BUY
$7.47 - $14.03 $449,776 - $844,760
60,211 New
60,211 $449,000
Q4 2018

Jan 16, 2019
SELL
$10.36 - $20.96 $338,999 - $685,853
-32,722 Closed
0 $0
Q3 2018

Oct 23, 2018
BUY
$17.77 - $22.9 $126,788 - $163,391
7,135 Added 27.89%
32,722 $710,000
Q2 2018

Jul 30, 2018
SELL
$17.33 - $23.4 $108,399 - $146,367
-6,255 Reduced 19.64%
25,587 $452,000
Q1 2018

Apr 26, 2018
SELL
$15.16 - $25.49 $7,959 - $13,382
-525 Reduced 1.62%
31,842 $670,000
Q4 2017

Jan 10, 2018
SELL
$14.27 - $16.79 $64,000 - $75,303
-4,485 Reduced 12.17%
32,367 $468,000
Q3 2017

Oct 25, 2017
BUY
$10.77 - $22.1 $396,896 - $814,429
36,852
36,852 $581,000

Others Institutions Holding ITCI

# of Institutions
379
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email